Histamine as an autocrine regulator of leukemic cell proliferation

Leukemia and Lymphoma

Volumn 36, Issue 3-4, 2000, Pages 367-373

  Malaviya, Rama ^a   Uckun, Fatih M ^a,b  

^a Parker Hughes Cancer Center   (United States)

^b PARKER HUGHES INSTITUTE   (United States)

Author keywords

Autocrine regulator; Histamine; Leukemia; Leukemic cell proliferation

Indexed keywords

ANTIHISTAMINIC AGENT; DIPHENHYDRAMINE; HISTAMINE; POLYCLONAL ANTIBODY;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CELL GROWTH; CELL IMMORTALIZATION; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL; PRIORITY JOURNAL; PROLYMPHOCYTE;

EID: 0033978205     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009148858     Document Type: Article

References (27)

1. Trigg ME, Gaynon P, Uckun FM: Acute lymphoblastic leukemia in children, in Holland JF, Fry EI, Bast RCJ, Kufe DW, Morton DL, Weichselbaum RR (eds): Cancer Medicine, 4th edition, Philadelphia, PA, Williams & Wilkins, 1996, p 1.
2. Poplack DJ: Acute lymphoblastic leukemia, in Pizzo PA, Poplack DG (eds): Principals and Practice of Pediatric Oncology, Philadelphia, PA, Lippincott, 1989, p 323.
3. Uckun FM, Fauci AS, Song CW, Mehta SR, Heerema NA, Gajl-Peczalska KJ, Ambrus JL. B-cell growth factor receptor expression and B cell growth factor response of leukemic B-cell precursors and B lineage lymphoid progenitor cells. Blood 70:1020-1034, 1987.
4. Uckun FM. Biology and Treatment of Childhood T-lineage Acute Lymphoblastic Leukemia (Review Article). Blood 91:735-746, 1998.
5. Uckun FM, Gesner T, Song CW, Myers DE, Mufson A. Leukemic B-cell precursors express functional receptors for human interleukin-3. Blood 73:533-542, 1989.
6. Uckun FM, Myers DE, Fauci AS, Ambrus JL. Leukemic B-cell precursors constitutively express functional receptors for human interleukin-1. Blood 74:761-776, 1989.
7. Uckun FM. Regulation of human B-cell ontogeny (Review). Blood 76:1908-1923, 1990.
8. Uckun FM, Ledbetter JA. Immunobiologic differences between normal and leukemic human B-cell precursors. Proc. Natl Acad. Sci. U.S.A. 85:8603-8607, 1988.
9. Ledbetter JA, Rabinovitch PS, June CH, Song CW, Clark EA, Uckun FM. Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19. Proc. Natl. Acad. Sci. U.S.A. 85:1897-1901, 1988.
10. Garcia-Caballero M, Neugebauer E, Campos R, Nunez-de-Castro I, Vara-Thorbeck C: Increased histidine decarboxylase (HDC) activity in human colorectal cancer: results of a study on ten patients. Agents Actions 23:357-360, 1988.
11. Brandes LJ, Bogdanovic RP, Cawker MD, LaBella FS. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels. Cancer Res. 47: 4025-4031, 1987.
12. Brandes LJ, Simons KJ, Bracken SP, Warrington RC. Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents. J. Clin. Oncol. 12: 1281-1290, 1994.
13. Brandes LJ, LaBella FS. Histamine and calcium are independently regulated intracellular mediators of lymphocyte mitogenesis. Biochem. Biophys. Res. Commun. 182: 786-93, 1992.
14. Bencsath M, Paloczi K, Szalai C, Szenthe A, Szeberenyi J, Falus A: Histidine decarboxylase in proliferation of healthy individuals and chronic lymphoid leukemia patients. Pathol Oncol Res 4:121-124, 1998.
15. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, T-Ahlgren L, Chelstrom LM, Burkhardt A, Bolen J, Myers DE. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267:886-891, 1995.
16. Uckun FM, Herman-Hatten K, Crotty ML, Sensel MG, Sather HN, Tuel-Ahlgren L, Sarquis MB, Bostrom B, Nachman JB, Steinherz PG, Gaynon PS, Heerema N. Clinical Significance of MLL-AF4 Fusion Transcript Expression in the Absence of a Cytogenetically Detectable t(4;11)(q21;q23) Chromosomal Translocation. Blood, 92(3):810-821, 1998.
17. Uckun FM, Downing JR, Gunther R, Chelstrom LM, Finnegan D, Land VJ, Borowitz MJ, Carroll AJ, Crist WM. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood 81:3052-3062, 1993.
18. Zhu DM, Narla RK, Fang WH, Chia NC, Uckun FM: Calphostin C triggers calcium - dependent apoptosis in human acute lymphoblastic leukemia cells. Clin Cancer Res 4:2967-2976, 1998.
19. Uckun FM, Gajl-Peczalska KJ, Kersey JH, Houston LL, Vallera DA: Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia. J Exp Med 163:347-368, 1986.
20. Nachman JB, Sather HN, Sensel MG, Trigg ME, Cherlow JM, Lukens JN, Wolff L, Uckun FM, and Gaynon PS. Improved Outcome with Augmented Post-Induction Therapy for Children With High Risk Acute Lymphoblastic Leukemia Who Show a Slow Early Response to Induction Therapy: lChildren's Cancer Group Study. New England Journal of Medicine, 338:1663-1671, 1998.
21. Uckun FM, Sensel MG, Sather HN, Gaynon PS, Arthur DC, Lange BJ, Steinherz PG, Kraft P, Hutchinson R, Nachman JB, Reaman GH, Heerema NA. Clinical Significance of Translocation t(1;19) in Childhood Acute Lymphoblastic Leukemia in the Context of Contemporary Therapies: A Report From The Children's Cancer Group. J. Clin. Oncol., 16(2): 527-535, 1998.
22. Uckun FM, Sather H, Gaynon P, Arthur D, Trigg M, Tubergen D, Nachman J, Steinherz P, Sensel M, Reaman G. Clinical Features and Treatment Outcome of Children with Myeloid Antigen Positive Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group. Blood, 90(1):28-35, 1997.
23. Uckun FM, Gaynon P, Sensel M, Nachman J, Trigg M, Steinherz P, Hutchinson R, Bostrom B, Lange B, Sather H, Reaman G. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: A Children's Cancer Group Study. J. Clin. Oncol., 15(6):2214-2221, 1997.
24. Schleimer RP, MacGlashan DW Jr, Schulman ES, Peters SP, Adams GK 3d, Adkinson NF Jr, Lichlenstein LM: Human mast cells and basophils-structure. function, pharmacology, and biochemistry. Clin Rev Allergy 1:327-341, 1983.
25. Costa JJ, Weller PF, Galli SJ: The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 278:1815-1822, 1997.
26. Malaviya R, Morrison AR, Pentland AP. Histamine in human epidermal cells is induced bu ultraviolet light injury. J. Invest. Dermatol. 106: 785-789, 1996.
27. Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsay NK. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N. Engl. J. Med. 329: 1296-1301, 1993.